Clarify Health Solutions, Inc., a developer of real-time care guidance technology solutions, closed $57m in Series B financing.
The round was led by KKR, through the firm’s Health Care Strategic Growth Fund.
The company intends to use the funds to expand its clinical transformation, sales, engineering, and data science teams, to acquire new data assets, and to accelerate the development of its digital care guidance platform.
Led by Jean Drouin, MD, CEO and Co-Founder, and Todd Gottula, President, CTO and Co-Founder, Clarify Health Solutions provides hospital, health insurance, and life sciences customers with financial services and consumer technologies coupled with clinical expertise needed to power innovative care delivery models. Its solutions deploy predictive analytics and machine learning on a comprehensive data set of over 20 terabytes – representing clinical, claims, social determinant, laboratory, and prescription data – to provide actionable insights and automate care navigation.
The company’s Care Journey Platform enables doctors to gain the confidence of matching patients to the most appropriate care, while patients benefit from real-time visibility and guidance.
Clarify delivers precise care guidance through its three primary solutions:
– Clarify Care Prism, a machine-learning analytics solution that provides case-mix adjusted insights on performance in value-based payment programs and beyond.
– Clarify Care Pilot, a real-time patient engagement solution that guides the patient through his or her care journey.
– Clarify Care Connect, a real-time care navigation solution that empowers clinicians to monitor and guide patients through their journey of care in real time.